Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

380
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
380
The Mantel-Cox Log-Rank Test01:19

The Mantel-Cox Log-Rank Test

965
The Mantel-Cox log-rank test is a widely used statistical method for comparing the survival distributions of two groups. It tests whether a statistically significant difference exists in survival times between the groups without assuming a specific distribution for the survival data, making it a non-parametric test. This flexibility makes the log-rank test particularly valuable in medical research and other fields where the timing of an event, such as death or disease recurrence, is of...
965
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

1.2K
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
1.2K
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

382
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
382
Confounding in Epidemiological Studies01:27

Confounding in Epidemiological Studies

554
Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This...
554
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

533
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
533

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Towards a Unified Theory for Semiparametric Data Fusion with Individual-Level Data.

Annals of statistics·2026
Same author

Household Transmission of Enterovirus D68, Washington and Oregon, United States, 2022-2024.

Emerging infectious diseases·2026
Same author

Lameness caused by intramuscular osteochondroma in semimembranosus muscle in a male cat.

JFMS open reports·2026
Same author

Early Implementation of Doxycycline Postexposure Prophylaxis at an Infectious Diseases Clinic in the Southern United States.

AIDS patient care and STDs·2026
Same author

Data sharing in stepped-wedge cluster randomized trials: suboptimal data availability despite "data available upon request".

Journal of clinical epidemiology·2026
Same author

Evaluating global health programmes targeting under-5 mortality: problems and recommendations.

BMJ global health·2026
Same journal

A Mixture of Distributed Lag Non-Linear Models to Account for Spatially Heterogeneous Exposure-Lag-Response Associations.

Statistics in medicine·2026
Same journal

Practical Considerations for Gaussian Process Modeling for Causal Inference in Quasi-Experimental Studies With Panel Data.

Statistics in medicine·2026
Same journal

Covariate Adjustment for Wilcoxon Two Sample Statistic and Test.

Statistics in medicine·2026
Same journal

Beyond Fixed Thresholds: Optimizing Summaries of Wearable Device Data via Piecewise Linearization of Quantile Functions.

Statistics in medicine·2026
Same journal

A Causal Framework for Evaluating the Total Effect of Strategies Aiming to Expand Screening and to Improve Outcomes.

Statistics in medicine·2026
Same journal

Causal Effects on Nonterminal Event Time With Application to Antibiotic Usage and Future Resistance.

Statistics in medicine·2026
See all related articles

Related Experiment Video

Updated: Jan 9, 2026

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

12.7K

Inference on Controlled Effects for Assessing Immune Correlates of Protection Based on a Cox Model.

Avi Kenny1,2, Lars van der Laan3, Peter Gilbert4,5

  • 1Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina, USA.

Statistics in Medicine
|December 10, 2025
PubMed
Summary
This summary is machine-generated.

Identifying immune correlates of protection (CoP) is crucial for vaccine development. This study introduces a faster analytical method to validate these biomarkers, potentially accelerating vaccine approval.

Keywords:
Cox proportional hazardscontrolled riskdose‐responsesurrogatevaccine

More Related Videos

An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection
08:14

An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection

Published on: October 6, 2015

10.6K
Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
06:03

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

1.7K

Related Experiment Videos

Last Updated: Jan 9, 2026

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

12.7K
An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection
08:14

An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection

Published on: October 6, 2015

10.6K
Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
06:03

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

1.7K

Area of Science:

  • Vaccinology
  • Biostatistics
  • Epidemiology

Background:

  • Identifying reliable immune correlates of protection (CoP) is vital for predicting vaccine efficacy and accelerating clinical trials.
  • Controlled risk (CR) curves are used to validate CoP by assessing their causal effect on disease risk.
  • Current methods for estimating CR curves rely on computationally intensive bootstrap inference.

Purpose of the Study:

  • To analytically derive the asymptotic variance of the controlled risk (CR) curve estimator.
  • To develop an analytic approach for constructing pointwise and uniform confidence bands for CR curves.
  • To provide a computationally efficient alternative to bootstrap methods for CoP validation.

Main Methods:

  • Analytical derivation of the asymptotic variance for the CR curve estimator.
  • Development of analytic methods for confidence band construction.
  • Evaluation of finite sample performance through simulation studies.
  • Application to real-world data from the mRNA-1273 COVID-19 vaccine efficacy trial (COVE).

Main Results:

  • An analytic method for estimating the asymptotic variance of the CR curve estimator was successfully derived.
  • Pointwise and uniform confidence bands can be constructed analytically, offering computational efficiency.
  • The proposed methods demonstrate good performance in simulation studies.
  • The approach was successfully applied to analyze data from a major COVID-19 vaccine trial.

Conclusions:

  • The study provides a computationally efficient analytical method for validating immune correlates of protection (CoP).
  • This approach can accelerate the assessment of vaccine efficacy and potentially expedite regulatory approval processes.
  • The findings offer a valuable tool for vaccine researchers and biostatisticians.